β-Aldehyde ketones as dual inhibitors of aldose reductase and α-glucosidase with antioxidant properties

被引:0
|
作者
Zhang, Xiaonan [1 ]
Chen, Huan [1 ]
Zhang, Xin [1 ]
Xu, Long [1 ]
Lei, Yanqi [1 ]
Liu, Wenchao [1 ]
Li, Lingyun [1 ]
Xu, Hulin [2 ]
Zhu, Changjin [1 ]
Ma, Bing [1 ]
机构
[1] Beijing Inst Technol, Sch Chem & Chem Engn, Zhongguancun South St, Beijing 100081, Peoples R China
[2] Beijing Qintian Sci & Technol Dev Co Ltd, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
SELECTIVE INHIBITORS; DERIVATIVES; CURCUMIN; COMPLEX; POTENT; IDENTIFICATION; COMPLICATIONS; HOLOENZYME; FIDARESTAT; RESOLUTION;
D O I
10.1039/d1nj03426j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this study, a series of phenyl beta-aldehyde ketones were designed and synthesized as novel dual inhibitors of aldose reductase (ALR2) and alpha-glucosidase. The results showed substantial inhibition of ALR2 and alpha-glucosidase by the synthetic compounds and also demonstrated the antioxidant activity of these inhibitors. Among them, compound 5l had the most potent inhibitory effect on both enzymes, with non-competitive inhibition patterns, and was the most effective antioxidant in tests for 2,2-diphenyl-1-picrylhydrazyl radical scavenging and lipid peroxidation suppression. High lipophilicity and negligible cytotoxicity were also observed for this compound. Analysis indicated that the beta-aldehyde ketone moiety might play a vital role in the inhibitory effect on the enzymes and that the phenolic hydroxy group was the key structure for intensifying the inhibitory and antioxidant activities. Overall, the results confirmed the successful synthesis of potent ALR2 and alpha-glucosidase inhibitors with antioxidant activity.
引用
收藏
页码:6165 / 6173
页数:9
相关论文
共 50 条
  • [41] ALDOSE AND ALDEHYDE REDUCTASE PROFILES IN HUMAN-KIDNEY
    STANGEBYE, LA
    HUNSAKER, LA
    VANDERJAGT, DL
    SIBBITT, WL
    EATON, RP
    CLINICAL RESEARCH, 1989, 37 (01): : A161 - A161
  • [42] PURIFICATION AND CHARACTERIZATION OF HUMAN TESTIS ALDOSE AND ALDEHYDE REDUCTASE
    TANIMOTO, T
    OHTA, M
    TANAKA, A
    IKEMOTO, I
    MACHIDA, T
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1991, 23 (04): : 421 - 428
  • [43] Structural and kinetic determinants of aldehyde reduction by aldose reductase
    Srivastava, S
    Watowich, SJ
    Petrash, JM
    Srivastava, SK
    Bhatnagar, A
    BIOCHEMISTRY, 1999, 38 (01) : 42 - 54
  • [44] Aldose reductase-catalyzed reduction of aldehyde phospholipids
    Srivastava, S
    Spite, M
    Trent, JO
    West, MB
    Ahmed, Y
    Bhatnagar, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) : 53395 - 53406
  • [45] Aldose reductase inhibitors improve myocardial reperfusion injury in mice by a dual mechanism
    Iwata, Kazumi
    Matsuno, Kuniharu
    Nishinaka, Toru
    Persson, Christina
    Yabe-Nishimura, Chihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 102 (01) : 37 - 46
  • [46] Ouinoline sulfones as inhibitors of aldose reductase
    Barrett, Kristen N.
    McKee, James
    Zanger, Murray
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [47] HUMAN-BRAIN ALDEHYDE REDUCTASES - RELATIONSHIP TO SUCCINIC SEMI-ALDEHYDE REDUCTASE AND ALDOSE REDUCTASE
    HOFFMAN, PL
    WERMUTH, B
    WARTBURG, JPV
    JOURNAL OF NEUROCHEMISTRY, 1980, 35 (02) : 354 - 366
  • [48] ACTIVATORS AND INHIBITORS OF LENS ALDOSE REDUCTASE
    JEDZINIAK, JA
    KINOSHITA, JH
    INVESTIGATIVE OPHTHALMOLOGY, 1971, 10 (05): : 357 - +
  • [49] THE MEDICINAL CHEMISTRY OF ALDOSE REDUCTASE INHIBITORS
    MILLER, DD
    ARES, JJ
    FELLER, DR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 188 (AUG): : 33 - MEDI
  • [50] ALDOSE REDUCTASE INHIBITORS AND DIABETIC COMPLICATIONS
    TOMLINSON, DR
    WILLARS, GB
    CARRINGTON, AL
    PHARMACOLOGY & THERAPEUTICS, 1992, 54 (02) : 151 - 194